Skip Navigation

A Randomized Open-Label Phase III Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer

Brief Summary

Type:
Colorectal

Study Type:
Treatment

Phase:
III

ClinicalTrials.gov Identifier:
NCT05425940

Study #:
STUDY00149034

Start Date:
Oct 16, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05425940

View Complete Trial Details & Eligibility at ClinicalTrials.gov